Paul Perreault was appointed Chief Executive Officer (CEO) and Managing Director of CSL Limited in July 2013. Since then, CSL has grown to become the world’s third largest biotechnology company with 27,000+ employees providing lifesaving products to 100+ countries.
Paul, who brings more than 30 years of experience in the global healthcare industry, joined CSL in 2004 when CSL Limited acquired Aventis Behring. Prior to his current role, Paul served as CSL Behring’s President and Executive Vice President of Worldwide Commercial Operations and Business Development. He also held several executive positions at Aventis Behring, including, Vice President and General Manager of Plasma Operations and Vice President and General Manager Hospital Products in North America and Puerto Rico.